HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Canaccord Genuity Remains Bullish on Heartware (HTWR) Following Agreement to Acquire Valtech Cardio
September 2, 2015 9:32 AM EDTCanaccord Genuity maintained a Buy rating and $106.00 price target on Heartware Int'l (NASDAQ: HTWR) following the company's agreement to acquire privately held Valtech Cardio. Analyst Jason Mills said that this is the type of deal to which investors commonly overreact; but once the dust settles, he would be a buyer of this stock.
Mills commented, "HeartWares agreement to acquire... More
Heartware International's (HTWR) Valtech Cardio Acquisition Doesn't Make Sense, Says Northland
September 2, 2015 9:18 AM EDTNorthland Capital Markets maintained an Underperform rating on Heartware International (NASDAQ: HTWR) with a price target of $60. Analyst Suraj Kalia said the company's acquisition of Valtech Cardio does not makes sense.
Kalia explained, "Valtech is a pre-revenue company developing surgical & transcatheter mitral repair / replacement... More
Raymond James Downgrades Heartware (HTWR) to Market Perform
September 2, 2015 8:36 AM EDTRaymond James downgraded Heartware Int'l (NASDAQ: HTWR) from Outperform to Market Perform and removed its price target (prior $102.00).
For an analyst ratings summary and ratings history on Heartware Int'l click here. For more ratings news on Heartware Int'l click here.
Shares of Heartware Int'l closed at $81.81 yesterday.
... MoreBTIG Downgrades Heartware Int'l (HTWR) to Neutral
September 2, 2015 8:13 AM EDTBTIG downgraded Heartware Int'l (NASDAQ: HTWR) from Buy to Neutral. The change follows its acquisition of Valtech.
"While we understand the rationale of this acquisition and it may prove to be a strong asset over the next 3-5 years, we anticipate there... More
Heartware (HTWR) to Acquire Valtech Cardio
September 1, 2015 4:25 PM EDTHeartware (NASDAQ: HTWR) announced today that it has entered into a definitive agreement to acquire Valtech Cardio, Ltd. ("Valtech"). Valtech is a privately held company that specializes in the development of innovative surgical and transcatheter valve repair and replacement devices for the treatment of the most prevalent heart valve diseases mitral valve regurgitation (MR) and... More
